These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial. Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, Hwu HG. J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540 [Abstract] [Full Text] [Related]
4. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. Hsu WY, Huang SS, Lee BS, Chiu NY. J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056 [Abstract] [Full Text] [Related]
5. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P. Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448 [Abstract] [Full Text] [Related]
10. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. Lim HK, Kim JJ, Pae CU, Lee CU, Lee C, Paik IH. Neuropsychobiology; 2010 May; 62(2):81-6. PubMed ID: 20523078 [Abstract] [Full Text] [Related]
11. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A. Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240 [Abstract] [Full Text] [Related]
12. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia. Citrome L, Du Y, Risinger R, Stankovic S, Claxton A, Zummo J, Bose A, Silverman BL, Ehrich EW. Int Clin Psychopharmacol; 2016 Mar; 31(2):69-75. PubMed ID: 26517202 [Abstract] [Full Text] [Related]
13. Intramuscular aripiprazole in the control of agitation. Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT. J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559 [Abstract] [Full Text] [Related]
15. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients. San L, Arranz B, Querejeta I, Barrio S, De la Gándara J, Pérez V. Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151 [Abstract] [Full Text] [Related]
16. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A. Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218 [Abstract] [Full Text] [Related]
17. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT. J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560 [Abstract] [Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. Katagiri H, Fujikoshi S, Suzuki T, Fujita K, Sugiyama N, Takahashi M, Gomez JC. BMC Psychiatry; 2013 Jan 11; 13():20. PubMed ID: 23311957 [Abstract] [Full Text] [Related]
19. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder. Centorrino F, Meyers AL, Ahl J, Cincotta SL, Zun L, Gulliver AH, Kinon BJ, Houston JP. Hum Psychopharmacol; 2007 Oct 11; 22(7):455-62. PubMed ID: 17708578 [Abstract] [Full Text] [Related]